PH25022A - Novel (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives - Google Patents

Novel (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives

Info

Publication number
PH25022A
PH25022A PH35811A PH35811A PH25022A PH 25022 A PH25022 A PH 25022A PH 35811 A PH35811 A PH 35811A PH 35811 A PH35811 A PH 35811A PH 25022 A PH25022 A PH 25022A
Authority
PH
Philippines
Prior art keywords
imidazol
ylmethyl
novel
benzimidazole derivatives
substituted benzimidazole
Prior art date
Application number
PH35811A
Other languages
English (en)
Inventor
Alfons H M Raeymaekers
Eddy J E Freyne
Gerard C Sanz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH25022A publication Critical patent/PH25022A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH35811A 1986-09-15 1987-09-14 Novel (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives PH25022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90790386A 1986-09-15 1986-09-15

Publications (1)

Publication Number Publication Date
PH25022A true PH25022A (en) 1991-01-28

Family

ID=25424835

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35811A PH25022A (en) 1986-09-15 1987-09-14 Novel (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives

Country Status (23)

Country Link
EP (1) EP0260744B1 (ko)
JP (1) JPS6485975A (ko)
KR (1) KR960014353B1 (ko)
CN (1) CN1020903C (ko)
AU (1) AU595064B2 (ko)
BG (1) BG61321B2 (ko)
CA (1) CA1323366C (ko)
CY (1) CY1803A (ko)
DE (1) DE3783107T2 (ko)
DK (1) DK174728B1 (ko)
ES (1) ES2053524T3 (ko)
FI (1) FI87781C (ko)
GR (1) GR3006841T3 (ko)
HK (1) HK123694A (ko)
HU (1) HU198039B (ko)
IE (1) IE60514B1 (ko)
IL (1) IL83892A (ko)
NO (1) NO167202C (ko)
NZ (1) NZ221729A (ko)
PH (1) PH25022A (ko)
PT (1) PT85692B (ko)
SU (1) SU1662350A3 (ko)
ZA (1) ZA876881B (ko)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
US5021448A (en) * 1990-02-22 1991-06-04 Ciba-Geigy Corporation Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
FR2663028B1 (fr) * 1990-06-08 1994-10-14 Roussel Uclaf Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5216003A (en) * 1992-01-02 1993-06-01 G. D. Searle & Co. Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
WO1995004723A1 (fr) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive
HUT75871A (en) * 1993-09-30 1997-05-28 Yamanouchi Co Azole derivatives and pharmaceutical compositions thereof
NZ279227A (en) * 1994-02-18 1997-11-24 Janssen Pharmaceutica Nv Dextrorotatory (+)-5-[3-chlorophenyl]-1h-imidazol-1-ylmethyl]-1h-benzimidazole derivatives (liarozole)
JPH09508915A (ja) * 1994-02-18 1997-09-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フェンノートシヤツプ 鏡像異性体的に純粋な（−）−リアロゾール
GB9418443D0 (en) * 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
US6696459B1 (en) 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DK0800519T3 (da) * 1994-12-22 2004-03-01 Ligand Pharm Inc Steroidreceptormodulatorforbindelser og fremgangsmåder
TW316902B (ko) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
EP0820989A4 (en) * 1995-03-01 1998-05-06 Yamanouchi Pharma Co Ltd IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION BASED ON SAID DERIVATIVES
US6288100B1 (en) * 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
DE19535500A1 (de) * 1995-09-25 1997-03-27 Bayer Ag Verfahren zur Herstellung von 3-Chlor-3'-nitro-4'-methoxybenzophenon
DK0882718T3 (da) * 1995-12-28 2005-12-12 Astellas Pharma Inc Benzimidazolderivater
BR9710002A (pt) 1996-06-27 1999-08-10 Janssen Pharmaceutica Nv N-[4-(heteroarilmetil)fenil]-heteroarilaminas
FR2751649B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
ATE231128T1 (de) 1997-02-21 2003-02-15 Takeda Chemical Industries Ltd Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
TW453999B (en) 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
HUP0100860A3 (en) * 1997-12-11 2003-03-28 Janssen Pharmaceutica Nv Retinoic acid mimetic anilides, process for their preparation and pharmaceutical compositions containing them
DE19831985A1 (de) 1998-07-16 2000-01-20 Bayer Ag Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
EP1189889B1 (en) * 1999-06-04 2003-12-17 Elan Pharma International Limited Compositions and methods for inhibiting cell death
WO2001068591A1 (en) 2000-03-16 2001-09-20 F. Hoffmann-La Roche Ag Carboxylic acid derivatives as ip antagonists
CN1329394C (zh) 2000-11-17 2007-08-01 武田药品工业株式会社 新咪唑衍生物、其制备方法及其用途
US6960586B2 (en) 2000-11-20 2005-11-01 Takeda Pharmaceutical Company Limited Imidazole derivatives, process for their preparation and their use
ATE440096T1 (de) 2000-12-08 2009-09-15 Takeda Pharmaceutical Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
US7405235B2 (en) 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US6492517B1 (en) 2001-07-19 2002-12-10 Air Products And Chemicals, Inc. Method for preparing halomethyl heterocyclic compounds
JP4634037B2 (ja) * 2001-11-16 2011-02-16 日本ケミファ株式会社 キサンチンオキシダーゼ阻害剤
CA2504448C (en) * 2002-11-01 2012-06-19 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
EP1654221A2 (en) * 2003-06-10 2006-05-10 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
FR2860235A1 (fr) * 2003-09-29 2005-04-01 Yang Ji Chemical Company Ltd Utilisation d'un compose de formule (i) inhibiteur de l'aromatase a des fins therapeutiques et composes de formule (i) en tant que tels
AU2005324492B2 (en) 2004-04-23 2012-06-07 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
CN101065363B (zh) * 2004-09-30 2012-05-02 詹森药业有限公司 可用作选择性雄激素受体调节剂（sarms）的新苯并咪唑衍生物
AU2005292317B2 (en) * 2004-09-30 2011-09-08 Janssen Pharmaceutica N.V. Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
NZ570539A (en) * 2006-01-24 2011-07-29 Janssen Pharmaceutica Nv 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
AU2007215247B2 (en) * 2006-02-10 2012-12-13 Transtech Pharma, Llc Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
KR101307497B1 (ko) * 2006-04-19 2013-09-11 주식회사 동진쎄미켐 디이미다졸계 화합물 및 이를 이용한 유기발광소자
CN100496308C (zh) * 2006-06-02 2009-06-10 上海烟草（集团）公司 造纸法再造烟叶半逆流多级萃取工艺
EP1992228A1 (en) * 2007-05-14 2008-11-19 Bayer CropScience AG Insecticidal substituted thiourea derivatives
EP2162450B1 (en) * 2007-05-23 2015-02-25 Allergan, Inc. ((bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
DE102009038950A1 (de) 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue antiparasitäre Kombination von Wirkstoffen
US9394290B2 (en) * 2010-10-21 2016-07-19 Universitaet Des Saarlandes Campus Saarbruecken Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
CA2850508A1 (en) * 2011-09-30 2013-04-04 Endo Pharmaceuticals Inc. Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
KR101884447B1 (ko) * 2015-07-06 2018-08-01 삼성에스디아이 주식회사 모노머, 유기막 조성물, 유기막, 및 패턴형성방법
CA3233464A1 (en) * 2021-10-04 2023-04-13 Bolt Biotherapeutics, Inc. Asymmetric bis-benzimidazole sting agonist immunoconjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (ko) * 1980-10-23 1984-07-13 Pfizer
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
EP0178413A1 (en) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles

Also Published As

Publication number Publication date
ES2053524T3 (es) 1994-08-01
PT85692A (en) 1987-10-01
HU198039B (en) 1989-07-28
KR880003935A (ko) 1988-06-01
HUT45051A (en) 1988-05-30
NO167202C (no) 1991-10-16
FI873977A (fi) 1988-03-16
IL83892A0 (en) 1988-02-29
DK174728B1 (da) 2003-10-06
FI87781B (fi) 1992-11-13
CN1020903C (zh) 1993-05-26
DE3783107D1 (de) 1993-01-28
CY1803A (en) 1987-09-09
JPH0587071B2 (ko) 1993-12-15
CN87106423A (zh) 1988-04-20
CA1323366C (en) 1993-10-19
IE60514B1 (en) 1994-07-27
GR3006841T3 (ko) 1993-06-30
EP0260744A3 (en) 1989-01-18
FI87781C (fi) 1993-02-25
NO873840L (no) 1988-03-16
KR960014353B1 (ko) 1996-10-15
PT85692B (pt) 1990-06-29
DK479487A (da) 1988-03-16
JPS6485975A (en) 1989-03-30
DK479487D0 (da) 1987-09-14
DE3783107T2 (de) 1993-04-22
IL83892A (en) 1991-11-21
AU7838587A (en) 1988-04-14
IE872487L (en) 1988-03-15
NO167202B (no) 1991-07-08
ZA876881B (en) 1989-04-26
SU1662350A3 (ru) 1991-07-07
AU595064B2 (en) 1990-03-22
NZ221729A (en) 1989-07-27
FI873977A0 (fi) 1987-09-14
EP0260744B1 (en) 1992-12-16
HK123694A (en) 1994-11-18
EP0260744A2 (en) 1988-03-23
NO873840D0 (no) 1987-09-14
BG61321B2 (bg) 1997-05-30

Similar Documents

Publication Publication Date Title
CY1803A (en) Novel (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives
AU7596587A (en) Benzimidazole derivatives
GB8521493D0 (en) Benzimidazole derivatives
AU6867487A (en) Benzimidazole derivatives
PH22303A (en) Substituted benzimidazole derivatives
GB8709654D0 (en) Pyrazole derivatives
ZA874863B (en) Novel 18-phenyloestrane derivatives
AU7216287A (en) Benzimidazole derivatives
ZA877765B (en) Imidazoles
ZA889194B (en) Novel benzimidazole derivatives
ZA885366B (en) Benzimidazole derivatives
PH24626A (en) Heterocyclic substituted benzimidazoles
IL83436A0 (en) 5-substituted-3-phenyl-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidines
GB8617083D0 (en) Imidazole derivatives
GB8619971D0 (en) Imidazole compounds
GB2199579B (en) Azole derivatives
ZA875299B (en) Imidazole derivative
ZA856187B (en) Benzimidazole derivatives
SG118994G (en) (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives
ZA868962B (en) Novel stabilized benzimidazole derivatives
LV5770A4 (lv) (1H-imidazol-1-ilmetil)aizvietota benzimidazola atvasinajumi
IE860564L (en) Substituted benzimidazoles
IE861349L (en) Azole derivatives
IE841611L (en) Benzimidazole derivatives
GB8407411D0 (en) Benzimidazole derivatives